NASDAQ
Innate Pharma S.A. (IPHA) has a revenue compound annual growth rate of -47.48% over 5 years and -16.97% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.